← 返回前沿论文

ATG5 介导的诱导性自噬维持实体瘤应激下 CAR-T 细胞的持久性

英文原题:ATG5-mediated inducible autophagy sustains CAR-T cell durability under solid tumor stress.

查看英文原题

ATG5-mediated inducible autophagy sustains CAR-T cell durability under solid tumor stress.

PubMed 2026/04/22(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

研究概要

这些发现共同表明,通过 ATG5 增强诱导性自噬能力可促进 CAR-T 细胞功能在肿瘤相关挑战下的维持,凸显了一种增强 CAR-T 细胞在实体瘤免疫治疗中持久性的靶向策略。

中文摘要

自噬在 T 细胞中是一种依赖情境的应激适应通路,但其在实体瘤环境中维持嵌合抗原受体(CAR)T 细胞功能的作用尚未充分明确。本研究考察 ATG5 介导的自噬调节是否有助于 CAR-T 细胞在肿瘤相关应激下保持功能持久性。ATG5 过表达(OE)的 CAR-T 细胞并未提高基础自噬活性,而是选择性增强了对诱导刺激的自噬通量。在模拟肿瘤的免疫抑制条件下,ATG5 OE CAR-T 细胞在长期抗原暴露期间仍保持细胞毒活性,效应细胞因子产生得以维持,氧化应激则有所降低。与体外结果一致,在经 IR 预处理的体内条件下,ATG5 OE CAR-T 细胞的抗肿瘤疗效增强,表现为肿瘤控制和生存改善;这与肿瘤浸润 CAR-T 细胞效应功能持续有关。总体而言,通过 ATG5 增强可诱导的自噬能力,有助于 CAR-T 细胞在肿瘤相关挑战下维持功能,提示这是一种增强实体瘤免疫治疗中 CAR-T 细胞持续性的靶向策略。

展开英文摘要原文

Autophagy functions as a context-dependent stress adaptation pathway in T cells; however, its role in sustaining chimeric antigen receptor (CAR)-T cell function within solid tumor environments remains insufficiently defined. In this study, we investigated whether ATG5-mediated autophagy regulation contributes to CAR-T cell functional durability under tumor-associated stress conditions. ATG5 overexpression (OE) CAR-T cells did not increase basal autophagy activity but instead selectively enhanced autophagy flux in response to inducible stimuli. Under tumor-mimicking immunosuppressive conditions, ATG5 OE CAR-T cells maintained cytotoxic activity during prolonged antigen exposure and exhibited preserved effector cytokine production together with reduced oxidative stress. Consistent with these in vitro findings, ATG5 OE CAR-T cells exhibited enhanced antitumor efficacy in vivo under IR-preconditioned settings, characterized by improved tumor control and survival, which was associated with sustained effector function of tumor-infiltrating CAR-T cells. Collectively, these findings demonstrate that reinforcing inducible autophagy capacity through ATG5 promotes the maintenance of CAR-T cell function under tumor-associated challenges, highlighting a targeted strategy to enhance CAR-T cell persistence in solid tumor immunotherapy.

论文信息

作者
Jung SE、Lim M、Jeong H、Moon Y、Seo H
单位
Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.South Korea
期刊
Frontiers in immunology2026
原文标识
PubMed 42099602 · DOI 10.3389/fimmu.2026.1720544